Showing the single result
Baricitinib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Baricitinib USP/Ph.Eur. 2 mg The Standard RA Anchor: The primary maintenance dose for adult patients with moderate-to-severe Rheumatoid Arthritis. Baricitinib USP/Ph.Eur. 4 mg The Dermatology/Severe Payload: High-potency dose utilized for Alopecia Areata and severe Atopic Dermatitis protocols. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure a consistent pharmacokinetic profile (Tmax of approx. 1 hour) for predictable immune suppression.
